In vitro characterization of CT‐001—a short‐acting factor VIIa with enhanced prohemostatic activity

BACKGROUND: Traumatic injury and the associated acute bleeding are leading causes of death in people aged 1 to 44 years. Acute bleeding in pathological and surgical settings also represents a significant burden to the society. Yet there are no approved hemostatic drugs currently available. While cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Sim, Derek S., Mallari, Cornell R., Teare, John M., Feldman, Richard I., Bauzon, Maxine, Hermiston, Terry W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265787/
https://www.ncbi.nlm.nih.gov/pubmed/34263099
http://dx.doi.org/10.1002/rth2.12530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265787/
https://www.ncbi.nlm.nih.gov/pubmed/34263099
http://dx.doi.org/10.1002/rth2.12530

Ejemplares similares